What is Premier Biotech?
Premier Biotech is a prominent entity in the diagnostic solutions market, specializing in rapid drug testing devices. Operating from its CAP Forensic accredited laboratory in Minneapolis, MN, the company offers tailored drug screening services. Its client base spans critical sectors including criminal justice and corrections, workplace safety programs, health and human services, and clinical applications, highlighting the broad utility and demand for its advanced diagnostic capabilities.
How much funding has Premier Biotech raised?
Premier Biotech has raised a total of $690K across 1 funding round:
Debt
$690K
Debt (2021): $690K with participation from PPP
Key Investors in Premier Biotech
PPP
Public-Private Partnership
What's next for Premier Biotech?
The recent major strategic investment positions Premier Biotech for accelerated growth and market expansion. This capital infusion is expected to fuel advancements in their diagnostic technology, enhance laboratory infrastructure, and broaden their service reach across existing and new market segments. The company's focus on customized drug screening solutions, backed by robust laboratory accreditation, provides a strong foundation for future development and increased market penetration.
See full Premier Biotech company page
